MURRAY RICHARD /CA/ 4
4 · Jounce Therapeutics, Inc. · Filed Apr 6, 2023
Insider Transaction Report
Form 4
MURRAY RICHARD /CA/
DirectorCEO and President
Transactions
- Sale
Common Stock
2023-04-04$1.85/sh−39,228$72,572→ 188,779 total
Footnotes (1)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The automatic sale instructions for the sell-to-cover were intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Securities Exchange Act of 1934, as amended, and to be interpreted to comply with the requirements of Rule 10b5-1(c), and these instructions were given on September 17, 2019.